# FDA Inspection 1007560 - SterRx, LLC - March 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/sterrx-llc/81ed2d81-bb72-4365-bcc0-842ca18b8695
Source feed: FDA_Inspections

> FDA Inspection 1007560 for SterRx, LLC on March 17, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1007560
- Company Name: SterRx, LLC
- Inspection Date: 2017-03-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1209342 - 2023-06-28](https://www.keypedia.com/records/fda_inspections/sterrx-llc/5abddc7d-afba-44e6-8e1f-6fe41c7585b9)
- [FDA Inspection 1156750 - 2021-11-04](https://www.keypedia.com/records/fda_inspections/sterrx-llc/66ca62f6-c033-45b1-9c2d-7519e21e23fc)

Company: https://www.keypedia.com/companies/sterrx-llc/e044d9e8-9ead-4e6d-908e-2741f789519b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c